• About
  • Subscribe
  • Advertise
  • Contact
Monday, December 15, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Campaign targets Aussies in their 50s at risk of AMD

by Myles Hume
October 27, 2020
in Local, Macular disease, News, Therapies
Reading Time: 3 mins read
A A
Only one in 10 Australians in their 50s can properly identify the major risk factors for AMD.

Only one in 10 Australians in their 50s can properly identify the major risk factors for AMD.

Share on FacebookShare on Twitter

Australian of the Year and ophthalmologist Dr James Muecke has endorsed a new campaign aimed at motivating Australians in their 50s to have a macula check after it was revealed most in this age group are unable to identify macular disease risk factors.

The Macular Disease Foundation Australia (MDFA)’s Check My Macula initiative includes an online risk assessment quiz for Australians over 50, which also allows people to book directly with an optometrist or schedule a reminder for an eye exam.

The MDFA is directing its efforts towards this age group, after a recent survey found one in seven Australians over the age of 50 has the early signs of AMD but may not know it until it’s too late.

https://www.insightnews.com.au/wp-content/uploads/2020/10/RUBBER-GLOVES_60.mp4

 

Caption: For the initiative, MDFA has produced this quirky television campaign voiced by Jean Kittson and Shane Jacobson.

The organisation’s CEO Ms Dee Hopkins said the statistics also showed more than 80% of people in their 50s know they should have an eye exam every two years but almost 40% gamble with their sight by skipping it. Additionally, only one in 10 Australians in their 50s can properly identify the major risk factors for AMD, being age, family history, smoking and lack of regular eye exams.

The Check My Macula campaign involves a one-minute, five-question quiz consisting to help Australia’s over-50s quickly and easily identify their risk factors for macular disease.

“Check My Macula makes personalised risk information about Australia’s leading causes of vision loss quick and easy to access,” Hopkins said.

Muecke has thrown his weight behind the campaign too. As an ophthalmologist, he has been fighting blindness for 30 years and has become concerned about the number of patients he’s treating for macular diseases such as age-related macular degeneration and diabetic eye disease.

Caption: Dr James Muecke’s video endorsement of the Check My Macula Campaign. 

“That’s why I’m asking every Australian aged 50-plus to visit www.CheckMyMacula.com.au,” Meucke said.

“Check My Macula is an online quiz that helps over-50s quickly and easily identify their risk factors for macular disease and diabetic eye disease and book an eye exam with your nearest optometrist.”

The campaign will feature posters and social media tiles that can be accessed by eyecare professionals.

With a shared goal of preventing macular disease, MDFA has prepared a digital toolkit that contains material eye health professionals can share with their patients in support of the campaign.

Channel 7 Sunrise Showbiz Editor Mr Nelson Aspen, 57, and Australian radio presenter Mr Brendan Jones, 52, are ambassadors for the initiative, along with award-winning journalist Ms Melissa Doyle and rugby league commentator Mr Andrew Voss.

It will also be supported by a television campaign voiced by MDFA ambassador Ms Jean Kittson and fellow Australian entertainer Mr Shane Jacobson.

More reading

Macular disease funding bequest opens doors for blue sky thinking

TGA approves first pharma option for proliferative diabetic retinopathy

Tackling treatment adherence in AMD

Tags: AustraliacampaignCheck My Maculamaculamacular diseaseMacular Disease Foundation AustraliaMDFAoptometrist

Related Posts

CPD: The ocular impacts of smoking and vaping

by Rob Mitchell
December 14, 2025

At the completion of this article, the reader should be able to… •  Describe current trends in tobacco smoking and...

This image shows a retinal detachment captured on Silverstone RGB with true colour optomap ultra-widefield imaging (left) and SS-OCT (right). Image: Optos.

Seeing in true colour with Optos

by Rob Mitchell
December 13, 2025

Silverstone RGB is Optos’ first ultra-widefield system combining red, green and blue laser channels with swept source OCT, giving clinicians...

Globally, more than 196 million people have AMD. Image: Jum/stock.adobe.com.

Aussie study pinpoints key genetic changes in AMD risk

by Staff Writer
December 12, 2025

Australian researchers have for the first time pinpointed specific genetic changes that increase the risk of severe, sight-threatening forms of...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited